PharmaCielo Ltd. announced that David Gordon has been appointed its Chief Corporate Officer (CCO) effective October 1, 2018. As CCO, Mr. Gordon will be responsible for overseeing and managing relationships with news media, analysts, shareholders and regulators in addition to ensuring alignment in achieving corporate responsibility and development objectives across international operations. Previously Mr. Gordon was a principal advisor to PharmaCielo as Managing Partner of Cohn & Wolfe | Canada, one of Canada's leading communication strategy firms, and since 2013 has served as Chair of the Canadian Council of PR Firms. Mr. Gordon was appointed to the Board of Directors of PharmaCielo Ltd. in 2016 and is a member of the Institute of Corporate Directors (ICD).